SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.00    -0.50 (-0.14%)
Bid:
351.00
Ask:
356.00
Spread: 5.00 (1.425%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Directorate Change

23 May 2023 07:00

RNS Number : 2624A
Caledonia Investments PLC
23 May 2023
Β 

Β 

Β 

APPOINTMENT OF CHIEF FINANCIAL OFFICER

Β 

The board of Caledonia Investments plc ("Caledonia" or the "Company") is pleased to announce that it has appointed Rob Memmott as Caledonia's Chief Financial Officer with effect from 1 September 2023.

Β 

Rob, a chartered accountant, has over 20 years' experience in senior financial leadership roles. He has significant listed company experience, having previously served as CFO of Arrow Global Group plc for seven years, which included its successful IPO, and John Laing Group plc before its take private transaction with KKR. Prior to this he was Finance Director of Leeds Bradford International Airport and Alfred McAlpine Infrastructure Services and CFO at Servisair-Globeground. Rob is also Treasurer and Pro Chancellor of the University of Sheffield.

Β 

Tim Livett, Caledonia's current Chief Financial Officer who advised Caledonia's board of his intention to retire in November 2022 once a suitable successor had been identified, will step down as a director on 1 September 2023 and leave the Company on 31 October 2023, to enable a smooth handover with Rob.

Β 

Commenting on the appointment, Mat Masters, Caledonia's Chief Executive Officer, said:

Β 

"We are delighted that Rob Memmott will be joining Caledonia. We expect his listed company and finance experience, across a range of industries and sectors will be highly complementary to our management team."

Β 

"I would also like again to extend the board's thanks to Tim Livett for his contribution to Caledonia and we wish him every success as he pursues a portfolio of non-executive roles."

Β 

Rob Memmott said:

Β 

"I am excited to be joining Caledonia, a company with a fantastic heritage built on a proven approach of investing in high-quality assets to create long-term value. I look forward to working with Mat and the team as we look to the opportunities ahead."

Β 

23 May 2023

Β 

For further information please contact:

Β 

Caledonia Investments plc

+44 20 7802 8080

Mat Masters

Chief Executive Officer

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

Β 

Β 

Notes:

Β 

1.

Mr Memmott served as Chief Financial Officer of John Laing Group plc before the company delisted on 23 September 2021. There are no further disclosures to be made pursuant to LR 9.6.13.

Β 

2.

Mr Memmott's remuneration package will be in accordance with Caledonia's approved remuneration policy. No special sign-on commitments or compensation payments for loss of benefits from a previous employer will be made in relation to his appointment.

Β 

3.

Information required by section 430 (2B) of the Companies Act 2006 relating to Mr Livett's cessation as a director of the Company will be available on Caledonia's website in due course.

Β 

Β 

END

Β 

Notes for editors:

Β 

Caledonia Investments plc

Caledonia is a self-managed investment trust company. Our aim is to grow net assets and dividends paid to shareholders, whilst managing risk to avoid the permanent loss of capital. We achieve this by investing in proven, well-managed businesses that combine long term growth characteristics with an ability to deliver increasing levels of income. We hold investments in both listed and private markets, covering a range of sectors and, particularly through the listed and fund investments, have a global reach.

Β 

For additional information on Caledonia, please visit www.caledonia.com.

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAPPUQCAUPWGRP
Date   Source Headline
14th Nov 20254:21 pmRNSHolding(s) in Company
14th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20251:27 pmRNSNet Asset Value(s)
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20254:08 pmRNSDirector/PDMR Shareholding
27th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSNet Asset Value(s)
1st Oct 20257:00 amRNSTotal Voting Rights
29th Sep 20252:55 pmRNSDirector/PDMR Shareholding
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20254:34 pmRNSDirector/PDMR Shareholding
18th Sep 20253:23 pmRNS-RUpdate from QuotedData
4th Sep 20259:31 amRNSNet Asset Value(s)
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20259:31 amRNSAgreement to sell interest in Stonehage Fleming
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20255:01 pmRNSDirector/PDMR Shareholding
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20259:47 amRNSNet Asset Value(s)
6th Aug 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.